Vancouver, B.C., - TheNewswire - July 7th, 2022 – Solarvest BioEnergy Inc. (“Solarvest” or the “Company”) (TSXV:SVS) is very pleased to announce that Richard Groome has agreed to chair the Company’s newly created financial advisory committee (the “Advisory Board”) and to support the recruitment of two additional members. The Advisory Committee will offer knowledge and skills in relation to fundraising, strategic acquisitions, marketing and to connect Solarvest with potential investors, customers, partners, service providers, employees and media.

CEO Gerri Greenham said “Solarvest has developed some very exciting and innovative new organic products that can disrupt the status quo. In particular, the Organic Omega 3 is a game-changer in the vast multi-billion USD Omega-3 global marketplace. The addition of Mr. Groome and his wealth of experience in the capital markets will enable us to fully exploit the uniqueness of our products.”

Richard (Rick) Groome, over the last three decades, was instrumental in creating and building two securities firms, Marleau Lemire and Groome Capital, which funded many successful biotechnology and nutraceutical companies. Among Mr. Groome's achievements are:

• Launching two securities trading and underwriting houses, with each achieving leading status within 3 years and one traded publicly on the Toronto Stock Exchange. 

• Managing and participating in more than 600 financings representing some $4 billion of small cap deals, with several companies successfully becoming billion and multi-billion-dollar companies. 

• Serving as past Director of the CDNX, the predecessor of the TSX Venture Exchange. 

• Serving on more than 30 boards of directors of emerging growth companies and experience in corporate governance and early start-up situations. 

Richard Groome added, “I’m excited to chair the Solarvest Advisory Committee and am looking forward to helping the Company penetrate the Omega-3 global marketplace with their unique new Organic Omega-3 line of products.“

An aggregate of 1,000,000 stock options exercisable at a price of $0.10 for a period of two years from the date of grant have been reserved for members of the Advisory Committee under the Company’s stock option plan.

About Solarvest

Solarvest BioEnergy Inc. is an algae biologics company whose production platform provides it with an extremely flexible system capable of producing numerous products from Omega 3 fatty acids to human therapeutic proteins. The Company has successfully developed, and produced the world’s only patented plant-based organic certified Omega-3 to satisfy the substantial demand for this essential nutrient.  fermentation facilities.

For further information contact:

Gerri Greenham, CEO

Tel: (647) 204-4095

Email: invest@solarvest.ca

Forward-Looking Statement

This news release contains forward-looking statements, which relate to future events or future performance and reflect management's current expectations and assumptions. Such forward-looking statements reflect management's current beliefs and are based on assumptions made by and information currently available to the Company. Investors are cautioned that these forward looking statements are neither promises nor guarantees, and are subject to risks and uncertainties that may cause future results to differ materially from those expected. These forward-looking statements are made as of the date hereof and, except as required under applicable securities legislation, the Company does not assume any obligation to update or revise them to reflect new events or circumstances.

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.